Document Detail

Long-term reduction of microalbuminuria after 3 years of angiotensin-converting enzyme inhibition by perindopril in hypertensive insulin-treated diabetic patients.
MedLine Citation:
PMID:  1580274     Owner:  NLM     Status:  MEDLINE    
We studied the long-term effects of the angiotensin-converting enzyme (ACE) inhibitor perindopril, administered for 36 months on glycemic control, creatinine clearance, and albuminuria in hypertensive insulin-treated diabetics. After 1 month treatment with placebo, 39 patients entered the study and received 4-8 mg perindopril/day. Within the first 3 months, diastolic blood pressure was normalized in 80% of the patients. From these, 23 were followed during a total of 3 years on perindopril therapy, and divided in three groups according to their initial urinary albumin excretion rate (AER): 11 had normal AER (less than 15 mg/24 hours), eight had microalbuminuria (AER 15-150 mg/24 hour), and four had AER greater than 150 mg/24 hours and had overt proteinuria. Long-term (3 years) diastolic blood pressure normalization (less than or equal to 90 mm Hg) was achieved throughout the study. Concomitant with blood pressure reduction, a long-term decrease in AER was observed in normo- and microalbuminuric patients. Macroproteinuria was unaffected by perindopril. Glycemic control and creatinine clearance remained stable during the whole study period. No major side effects were observed. We conclude that perindopril safely produces a long-term normalization of elevated blood pressure in hypertensive insulin-treated diabetics without affecting glycemic control. Blood pressure normalization is associated with long-term AER reduction in normo- and microalbuminuric patients.
M P Hermans; S M Brichard; I Colin; P Borgies; J M Ketelslegers; A E Lambert
Related Documents :
9758314 - Does aspirin interfere with the therapeutic efficacy of angiotensin-converting enzyme i...
10333164 - Undesirable blood pressure changes under naturalistic treatment with moclobemide, a rev...
8742494 - Blood pressure regulation by the kallikrein-kinin system.
10930064 - A depressed myocardium.
7010884 - The ocular responses of oral administration of penbutolol in the glaucomatous patient.
2760254 - The renal function and blood pressure effects of dilevalol in the normotensive and hype...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The American journal of medicine     Volume:  92     ISSN:  0002-9343     ISO Abbreviation:  Am. J. Med.     Publication Date:  1992 Apr 
Date Detail:
Created Date:  1992-06-05     Completed Date:  1992-06-05     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0267200     Medline TA:  Am J Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  102S-107S     Citation Subset:  AIM; IM    
Department of Internal Medicine, Louvain University School of Medicine, Brussels, Belgium.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Albuminuria / complications,  drug therapy*
Analysis of Variance
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
Blood Glucose / analysis
Creatinine / metabolism
Diabetes Complications*
Diabetes Mellitus / drug therapy
Diabetic Nephropathies / complications,  drug therapy*
Hypertension / complications,  drug therapy*
Indoles / therapeutic use*
Insulin / therapeutic use
Middle Aged
Reg. No./Substance:
0/Angiotensin-Converting Enzyme Inhibitors; 0/Blood Glucose; 0/Indoles; 11061-68-0/Insulin; 60-27-5/Creatinine; 82834-16-0/Perindopril

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Diagnosis and interventions in lower respiratory tract infections.
Next Document:  Effect of the renin-angiotensin system in the vascular disease of type II diabetes mellitus.